Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Search content at Korea University Pure
Home
Profiles
Research units
Equipment
Research output
Press/Media
Immunogenic clearance-mediated cancer vaccination
Gi Hoon Nam
, Yoosoo Yang
,
In San Kim
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
1
Link opens in a new tab
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunogenic clearance-mediated cancer vaccination'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Immunogenic
100%
Cancer Vaccination
100%
Immune Checkpoint Blockade
100%
Tumor
33%
T Cells
33%
Cancer Patients
33%
Cancer Vaccine
33%
Antigen-presenting Cells
33%
Dendritic Cells
33%
Tumor Antigen
33%
Antitumor Activity
33%
In Cancer
33%
Therapeutic Strategies
33%
Anticancer Immunotherapy
33%
Cancer Cells
33%
Phagocytosis
33%
Therapeutic Efficacy
33%
T-cell Mediated
33%
Tumor-specific T Cells
33%
Immunogenic Cell Death
33%
Cold Tumor
33%
Cross-priming
33%
Cancer-immunity Cycle
33%
Immunosuppressive Microenvironment
33%
Tumor Neoantigens
33%
Immunosurveillance
33%
Immunology and Microbiology
T Cell
100%
Immune Checkpoint Blockade
100%
Cancer Cell
66%
Cell Death
33%
Tumor Immunity
33%
Tumor Antigen
33%
Dendritic Cell
33%
Tumor Vaccine
33%
Antigen-Presenting Cell
33%
Antineoplastic Activity
33%
Immunotherapy
33%
Immunosurveillance
33%
Immunosuppressive Drug
33%
Cell Phagocytosis
33%
Neoantigen
33%
Cross-Presentation
33%